A
Actelion Pharmaceuticals
Biotech & Life Sciences · Allschwil, Switzerland · Founded 1997 · IPO 2013
Actelion Pharmaceuticals mafia
Startups founded by Actelion Pharmaceuticals alumni
Former Actelion Pharmaceuticals employees who went on to start their own companies. Sorted by Dealroom signal score.
Isaac KobrinSwitzerland
Alexandre MottaBrazil
Harris FienbergUnited States
Jean-Paul ClozelSwitzerland
Roman EmingerSwitzerland
Helene Peyro-Saint-PaulFrance
Lea ChevryFranceGlobal footprint
Where Actelion Pharmaceuticals has talent and traffic
team presence
across markets
Talent graph
The shape of Actelion Pharmaceuticals's talent
Dealroom maps Actelion Pharmaceuticals's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.
Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.
Patent intelligence
$304M patent portfolio · 127 active families
Where Actelion Pharmaceuticals concentrates vs peers
Each axis is a top-10 topic across Actelion Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Capital deployed
Actelion Pharmaceuticals's 4 investments and acquisitions.
Every disclosed deal where Actelion Pharmaceuticals appeared as a backer or acquirer, 2003–2017. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
4 deals across Actelion Pharmaceuticals's capital deployment.
Where the deals concentrate by sector, stage, and decade.
02 · Portfolio market map
Actelion Pharmaceuticals's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
What the market is saying about Actelion Pharmaceuticals
An AI-synthesized read of the highest-engagement posts about Actelion Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Actelion Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.